Raddeanin A

CAS No. 89412-79-3

Raddeanin A( —— )

Catalog No. M19236 CAS No. 89412-79-3

Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 139 In Stock
5MG 85 In Stock
10MG 140 In Stock
25MG 236 In Stock
50MG 342 In Stock
100MG 483 In Stock
200MG 691 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Raddeanin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.
  • Description
    Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Aurora Kinase
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89412-79-3
  • Formula Weight
    897.11
  • Molecular Formula
    C47H76O16
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (55.74 mM)
  • SMILES
    C1C(CC[C@@]2(CC[C@]3([C@@]4(CC[C@H]5C([C@H](CC[C@@]5([C@H]4CC=C3[C@H]12)C)O[C@@H]1OC[C@@H]([C@@H]([C@H]1O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)CO)O)O)(C)C)C)C)C(=O)O)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Guan YY,et al. Phytomedicine. 2015 Jan 15;22(1):103-10.
molnova catalog
related products
  • Barasertib

    A potent, highly selective Aurora B inhibitor with IC50 of 0.37 nM; displays >1,000-fold selectivity over Aurora B kinase.

  • Danusertib

    A potent, ATP-competitive Aurora kinase inhibitor with IC50 of 13,79 and 61 nM for Aurora A, B and C, respectively; Also inhibits Abl, RET, and FGFR1 (IC50=25,31, and 47 nM).

  • MK-5108

    MK-5108 (VX-689) is a potent, highly selective Aurora-A kinase inhibitor with IC50 of 0.064 nM.